(Q43054010)

13 November 2017

title

Circulating obestatin levels in normal and Type 2 diabetic subjects (English)

1 reference

13 November 2017

St-Pierre DH

1

1 reference

13 November 2017

Settanni F

2

1 reference

13 November 2017

Olivetti I

3

1 reference

13 November 2017

Gramaglia E

4

1 reference

13 November 2017

Tomelini M

5

1 reference

13 November 2017

Granata R

6

1 reference

13 November 2017

Prodam F

7

1 reference

13 November 2017

Benso A

8

1 reference

13 November 2017

Ghigo E

9

1 reference

13 November 2017

Broglio F

10

1 reference

13 November 2017

publication date

1 April 2010

1 reference

Journal of Endocrinological Investigation

13 November 2017

published in

1 reference

13 November 2017

volume

33

1 reference

13 November 2017

issue

4

1 reference

13 November 2017

page(s)

211-214

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03345780

13 November 2017

exact match

0 references

cites work

Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake

1 reference

https://api.crossref.org/works/10.1007%2FBF03345780

Obestatin reduces food intake and suppresses body weight gain in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345780

Preproghrelin-derived peptide, obestatin, fails to influence food intake in lean or obese rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345780

Lack of interaction between peripheral injection of CCK and obestatin in the regulation of gastric satiety signaling in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345780

Little or no ability of obestatin to interact with ghrelin or modify motility in the rat gastrointestinal tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345780

Effect of peripheral obestatin on gastric emptying and intestinal contractility in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345780

Effect of peripheral obestatin on food intake and gastric emptying in ghrelin-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345780

Peripheral obestatin has no effect on feeding behavior and brain Fos expression in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345780

Effects of obestatin on energy balance and growth hormone secretion in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345780

Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345780

Inhibitory effect of obestatin on glucose-induced insulin secretion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345780

Decreased obestatin in plasma in metabolically obese, normal-weight men with normal glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345780

Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345780

Plasma obestatin levels are lower in obese and post-gastrectomy subjects, but do not change in response to a meal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345780

Plasma obestatin concentrations are negatively correlated with body mass index, insulin resistance index, and plasma leptin concentrations in obesity and anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345780

Plasma obestatin is lower at fasting and not suppressed by insulin in insulin-resistant humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345780

Obestatin and ghrelin in obese and in pregnant women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345780

Characteristics associated with fasting appetite hormones (obestatin, ghrelin, and leptin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345780

Relation of plasma obestatin levels to bmi, gender, age and insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345780

Obestatin does not activate orphan G protein-coupled receptor GPR39

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345780

GPR39 signaling is stimulated by zinc ions but not by obestatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345780

Central and peripheral roles of ghrelin on glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345780

Circulating obestatin levels in normal subjects and in patients with impaired glucose regulation and type 2 diabetes mellitus

21 January 2018

1 reference

12 December 2020

Circulating preprandial ghrelin to obestatin ratio is increased in human obesity

1 reference

12 December 2020

Obestatin and ghrelin levels in obese children and adolescents before and after reduction of overweight.

1 reference

12 December 2020

Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat

1 reference

12 December 2020

Obestatin, acyl ghrelin, and des-acyl ghrelin responses to an oral glucose tolerance test in the restricting type of anorexia nervosa

1 reference

12 December 2020

Plasma obestatin levels in normal weight, obese and anorectic women

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03345780

1 reference

Dimensions Publication ID

13 November 2017

1047139200

0 references

1 reference